The global Varicella Vaccine market size was valued at US$ 4658 million in 2024 and is forecast to a readjusted size of USD 7744 million by 2031 with a CAGR of 7.6% during review period.
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
Global Varicella Vaccine key players include Merck, Shanghai Institute, Changsheng, Keygen, GSK, etc.
Asia is the largest market, with a share over 35%, followed by US and Europe, both have a share over 55%.
In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%. And in terms of application, the largest application is Kids Injection, followed by Adults Injection, etc.
This report is a detailed and comprehensive analysis for global Varicella Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Varicella Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Dose), 2020-2031
Global Varicella Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Dose), 2020-2031
Global Varicella Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Dose), 2020-2031
Global Varicella Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (USD/Dose), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Varicella Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Varicella Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross, Biken, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Varicella Vaccine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Injection
Freeze-Dried Powder
麻豆原创 segment by Application
Kids Injection
Adults Injection
Major players covered
Merck
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Varicella Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Varicella Vaccine, with price, sales quantity, revenue, and global market share of Varicella Vaccine from 2020 to 2025.
Chapter 3, the Varicella Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Varicella Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Varicella Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Varicella Vaccine.
Chapter 14 and 15, to describe Varicella Vaccine sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Varicella Vaccine Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Injection
1.3.3 Freeze-Dried Powder
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Varicella Vaccine Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Kids Injection
1.4.3 Adults Injection
1.5 Global Varicella Vaccine 麻豆原创 Size & Forecast
1.5.1 Global Varicella Vaccine Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Varicella Vaccine Sales Quantity (2020-2031)
1.5.3 Global Varicella Vaccine Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Varicella Vaccine Product and Services
2.1.4 Merck Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Merck Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Varicella Vaccine Product and Services
2.2.4 GSK Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 GSK Recent Developments/Updates
2.3 Shanghai Institute
2.3.1 Shanghai Institute Details
2.3.2 Shanghai Institute Major Business
2.3.3 Shanghai Institute Varicella Vaccine Product and Services
2.3.4 Shanghai Institute Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Shanghai Institute Recent Developments/Updates
2.4 BCHT
2.4.1 BCHT Details
2.4.2 BCHT Major Business
2.4.3 BCHT Varicella Vaccine Product and Services
2.4.4 BCHT Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 BCHT Recent Developments/Updates
2.5 Changsheng
2.5.1 Changsheng Details
2.5.2 Changsheng Major Business
2.5.3 Changsheng Varicella Vaccine Product and Services
2.5.4 Changsheng Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Changsheng Recent Developments/Updates
2.6 Keygen
2.6.1 Keygen Details
2.6.2 Keygen Major Business
2.6.3 Keygen Varicella Vaccine Product and Services
2.6.4 Keygen Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Keygen Recent Developments/Updates
2.7 Green Cross
2.7.1 Green Cross Details
2.7.2 Green Cross Major Business
2.7.3 Green Cross Varicella Vaccine Product and Services
2.7.4 Green Cross Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Green Cross Recent Developments/Updates
2.8 Biken
2.8.1 Biken Details
2.8.2 Biken Major Business
2.8.3 Biken Varicella Vaccine Product and Services
2.8.4 Biken Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Biken Recent Developments/Updates
3 Competitive Environment: Varicella Vaccine by Manufacturer
3.1 Global Varicella Vaccine Sales Quantity by Manufacturer (2020-2025)
3.2 Global Varicella Vaccine Revenue by Manufacturer (2020-2025)
3.3 Global Varicella Vaccine Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Varicella Vaccine by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Varicella Vaccine Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Varicella Vaccine Manufacturer 麻豆原创 Share in 2024
3.5 Varicella Vaccine 麻豆原创: Overall Company Footprint Analysis
3.5.1 Varicella Vaccine 麻豆原创: Region Footprint
3.5.2 Varicella Vaccine 麻豆原创: Company Product Type Footprint
3.5.3 Varicella Vaccine 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Varicella Vaccine 麻豆原创 Size by Region
4.1.1 Global Varicella Vaccine Sales Quantity by Region (2020-2031)
4.1.2 Global Varicella Vaccine Consumption Value by Region (2020-2031)
4.1.3 Global Varicella Vaccine Average Price by Region (2020-2031)
4.2 North America Varicella Vaccine Consumption Value (2020-2031)
4.3 Europe Varicella Vaccine Consumption Value (2020-2031)
4.4 Asia-Pacific Varicella Vaccine Consumption Value (2020-2031)
4.5 South America Varicella Vaccine Consumption Value (2020-2031)
4.6 Middle East & Africa Varicella Vaccine Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Varicella Vaccine Sales Quantity by Type (2020-2031)
5.2 Global Varicella Vaccine Consumption Value by Type (2020-2031)
5.3 Global Varicella Vaccine Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Varicella Vaccine Sales Quantity by Application (2020-2031)
6.2 Global Varicella Vaccine Consumption Value by Application (2020-2031)
6.3 Global Varicella Vaccine Average Price by Application (2020-2031)
7 North America
7.1 North America Varicella Vaccine Sales Quantity by Type (2020-2031)
7.2 North America Varicella Vaccine Sales Quantity by Application (2020-2031)
7.3 North America Varicella Vaccine 麻豆原创 Size by Country
7.3.1 North America Varicella Vaccine Sales Quantity by Country (2020-2031)
7.3.2 North America Varicella Vaccine Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Varicella Vaccine Sales Quantity by Type (2020-2031)
8.2 Europe Varicella Vaccine Sales Quantity by Application (2020-2031)
8.3 Europe Varicella Vaccine 麻豆原创 Size by Country
8.3.1 Europe Varicella Vaccine Sales Quantity by Country (2020-2031)
8.3.2 Europe Varicella Vaccine Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Varicella Vaccine Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Varicella Vaccine Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Varicella Vaccine 麻豆原创 Size by Region
9.3.1 Asia-Pacific Varicella Vaccine Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Varicella Vaccine Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Varicella Vaccine Sales Quantity by Type (2020-2031)
10.2 South America Varicella Vaccine Sales Quantity by Application (2020-2031)
10.3 South America Varicella Vaccine 麻豆原创 Size by Country
10.3.1 South America Varicella Vaccine Sales Quantity by Country (2020-2031)
10.3.2 South America Varicella Vaccine Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Varicella Vaccine Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Varicella Vaccine Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Varicella Vaccine 麻豆原创 Size by Country
11.3.1 Middle East & Africa Varicella Vaccine Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Varicella Vaccine Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Varicella Vaccine 麻豆原创 Drivers
12.2 Varicella Vaccine 麻豆原创 Restraints
12.3 Varicella Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Varicella Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Varicella Vaccine
13.3 Varicella Vaccine Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Varicella Vaccine Typical Distributors
14.3 Varicella Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Merck
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken
听
听
*If Applicable.
